CCAR2 and breast carcinoma: The roles of DBC1 in cancer have been studied, for example, DBC1 is able to inhibit breast cancer progression by suppressing the deacetylase activity of sirtuin‐type deacetylase (SIRT1), a NAD+‐dependent deacetylase involved in aging and stress responses, and promoting cellular apoptosis [21].